| AOP | adverse outcome pathways |
| BMD | benchmark dose |
| CDC | Centers for Disease Control and Prevention |
| CEBS | Chemical Effects in Biological Systems |
| cDNA | complementary DNA |
| CMAP | Connectivity Map |
| EAGMST | Extended Advisory Group for Molecular Screening and Toxicogenomics |
| ECHA | European chemicals agency |
| ECVAM | European Centre for the Validation of Alternative Methods |
| EFSA | European Food Safety Authority |
| eUTOPIA | A solUTion for Omics data PreprocessIng and Analysis |
| FAIR | Findable, Accessible, Interoperable and Reusable Data Principle |
| FDA | Food and Drug Administration |
| GEO | Gene Expression Omnibus |
| GO | gene ontology |
| GTEx | Genotype-Tissue Expression |
| JRC | Joint Research Centre |
| L1000 | Library of Integrated Network-Based Cellular Signatures 1000 |
| MIAME | Minimum Information About a Microarray Experiment |
| MINSEQE | Minimal Information about a high throughput SEQuencing Experiment |
| MOA | mechanism of action |
| NCT | National Center for Toxicogenomics |
| NCTR | National Center for Toxicological Research |
| NIEHS | National Institute of Environmental Health Sciences |
| NIH | National Institutes of Health |
| NIOSH | The National Institute for Occupational Safety and Health |
| NTP | The National Toxicology Program |
| OECD | Organisation for Economic Co-operation and Development |
| TG-GATE | Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System |
| PCR | polymerase chain reaction |
| POD | point of departure |
| QSAR | quantitative structure activity relationship |
| REACH | Registration, Evaluation, Authorisation and Restriction of Chemicals |
| RNA-Seq | RNA sequencing |
| scRNA-Seq | single-cell RNA sequencing |
| TGx | toxicogenomics |
| 3R | Replacement, Reduction and Refinement in animal testing |